Fed. Circ.'s Vimovo Ruling Harms Innovation, Horizon Says
The Federal Circuit has heightened the standard for patenting new drugs by requiring companies to prove that new inventions are effective to satisfy written description requirements, Horizon Pharma and Nuvo Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article